These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 6968766)

  • 1. Generation of cytotoxic lymphocytes to syngeneic tumors by using co-stimulator (Interleukin 2): in vivo activity.
    Mills GB; Carlson G; Paetkau V
    J Immunol; 1980 Nov; 125(5):1904-9. PubMed ID: 6968766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation of cytotoxic lymphocytes to syngeneic tumor by using co-stimulator (Interleukin 2).
    Mills GB; Paetkau V
    J Immunol; 1980 Nov; 125(5):1897-903. PubMed ID: 6159395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin 2-dependent activation of tumor-specific cytotoxic T lymphocytes in vivo.
    Ley V; Langlade-Demoyen P; Kourilsky P; Larsson-Sciard EL
    Eur J Immunol; 1991 Mar; 21(3):851-4. PubMed ID: 2009918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo activity of lymphokine-activated macrophages in host defense against neoplasia.
    Fernandez-Cruz E; Ulich T; Schreiber RD
    J Immunol; 1985 May; 134(5):3489-96. PubMed ID: 3920323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell-mediated immune responses in vitro. II. Simultaneous generation of cytotoxic lymphocyte responses to two sets of alloantigens of limited cross-reactivity.
    Peavy DL; Pierce CW
    J Immunol; 1975 Dec; 115(6):1515-20. PubMed ID: 1184965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generation of long-term T-lymphoid cell lines with specific cytotoxic reactivity for a syngeneic murine lymphoma.
    Eberlein TJ; Rosenstein M; Spiess PJ; Rosenberg SA
    J Natl Cancer Inst; 1982 Jul; 69(1):109-16. PubMed ID: 6980314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristics of an antigen-specific helper factor that enhances the in vitro generation of cytotoxic cells directed against a syngeneic tumor.
    Kilburn DG; Talbot FO; Levy JG
    J Immunol; 1981 Dec; 127(6):2465-9. PubMed ID: 6170706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunotherapy of established tumors in mice by intratumoral injection of an adenovirus vector harboring the human IL-2 cDNA: induction of CD8(+) T-cell immunity and NK activity.
    Slos P; De Meyer M; Leroy P; Rousseau C; Acres B
    Cancer Gene Ther; 2001 May; 8(5):321-32. PubMed ID: 11477452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of suppressor cells in mice bearing syngeneic mastocytoma.
    Takei F; Levy JG; Kilburn DG
    J Immunol; 1977 Feb; 118(2):412-7. PubMed ID: 65423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-estrogens potentiate the immunotherapy of the P815 murine mastocytoma by cytotoxic T lymphocytes.
    Nagy E; Baral E; Kangas L; Berczi I
    Anticancer Res; 1997; 17(2A):1083-8. PubMed ID: 9137453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor cell surface expression of granulocyte-macrophage colony-stimulating factor elicits antitumor immunity and protects from tumor challenge in the P815 mouse mastocytoma tumor model.
    Soo Hoo W; Lundeen KA; Kohrumel JR; Pham NL; Brostoff SW; Bartholomew RM; Carlo DJ
    J Immunol; 1999 Jun; 162(12):7343-9. PubMed ID: 10358185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specific adoptive therapy of established leukemia with syngeneic lymphocytes sequentially immunized in vivo and in vitro and nonspecifically expanded by culture with Interleukin 2.
    Cheever MA; Greenberg PD; Fefer A
    J Immunol; 1981 Apr; 126(4):1318-22. PubMed ID: 6970768
    [No Abstract]   [Full Text] [Related]  

  • 13. Modulation of immune effector cell cytolytic activity and tumour growth inhibition in vivo by Ukrain (NSC 631570).
    Liepins A; Nowicky JW
    Drugs Exp Clin Res; 1996; 22(3-5):103-13. PubMed ID: 8899312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of Tumor-like assay conditions, lonizing radiation, and hyperthermia on immune lysis of tumor cells by cytotoxic T-lymphocytes.
    Harris JW
    Cancer Res; 1976 Aug; 36(8):2733-9. PubMed ID: 6145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Helper cells active in the generation of cytotoxicity to a syngeneic tumor.
    Hancock EJ; Kilburn DG; Levy JG
    J Immunol; 1981 Oct; 127(4):1394-7. PubMed ID: 6168688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adoptive therapy of established syngeneic leukemia by cells primarily sensitized in vitro.
    Cheever MA; Greenberg PD; Fefer A
    Cancer Res; 1981 Jul; 41(7):2658-63. PubMed ID: 7018668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lectin-dependent cell-mediated cytotoxicity: assessment of cytotoxic reactivity following challenge with syngeneic tumors.
    Laux DC; Parker BM; DiSciullo SO; Petrarca MA; McAllister CG
    J Natl Cancer Inst; 1984 Mar; 72(3):667-72. PubMed ID: 6583449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The response of murine splenic lymphocytes to concanavalin A and to co-stimulator.
    Sanderson RJ; Rulon K; Groeneboer EG; Talmage DW
    J Immunol; 1980 Jan; 124(1):207-14. PubMed ID: 7350227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Humoral mechanisms of the membrano-toxic effects of mastocytoma P815 and leukemia EL4 cells].
    Medvedev AE; Fuks BB
    Biull Eksp Biol Med; 1989 Aug; 108(8):194-6. PubMed ID: 2508789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD8+ cytotoxic T cell repertoire implicated in grafts-versus-leukemia effect in a murine bone marrow transplantation model.
    de La Selle V; Riché N; Dorothé G; Bruley-Rosset M
    Bone Marrow Transplant; 1999 May; 23(9):951-8. PubMed ID: 10338053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.